SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-172000
Filing Date
2014-04-30
Accepted
2014-04-30 16:05:10
Documents
5
Period of Report
2014-06-12
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d657545ddef14a.htm DEF 14A 658432
2 GRAPHIC g657545g72d93.jpg GRAPHIC 10666
3 GRAPHIC g657545g88h87.jpg GRAPHIC 8007
4 GRAPHIC g657545pc_pg01.jpg GRAPHIC 140587
5 GRAPHIC g657545pc_pg02.jpg GRAPHIC 123613
  Complete submission text file 0001193125-14-172000.txt   1049837
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19825 | Film No.: 14798675
SIC: 2834 Pharmaceutical Preparations